Literature DB >> 9744142

Once-daily budesonide: 400 micrograms once daily is as effective as 200 micrograms twice daily in controlling childhood asthma. PETITE Research Group.

L M Campbell1, B Bodalia, C A Gogbashian, S D Gunn, P J Humphreys, J P Powell.   

Abstract

One hundred and sixty seven children on 0-200 microgram/day of inhaled steroid with asthma symptoms and sub-optimal peak flow values (less than 90% of that predicted for their height) were randomly allocated either 400 microgram once daily (nocte with placebo o.m.) or 200 mircrogram twice daily of budesonide Turbohaler for 8 weeks. Bronchdilator usage and symptoms were reduced in both groups at 4 and 8 weeks compared with baseline. There was a significant increase within both groups in morning and evening PEF after 4 and 8 weeks. The increase in evening PEF after 8 weeks was greater in the once-daily group than in the twice-daily group but there were no other significant differences between the groups (morning: +24.6 l/min vs 15.2 l/min, p = 0.059; evening: + 19.7 l/min vs +8.31 l/min; p = 0.013). Budesonide Turbohaler 400 microgram once daily is therefore as effective as 200 microgram twice daily in achieving asthma control in children.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9744142

Source DB:  PubMed          Journal:  Int J Clin Pract        ISSN: 1368-5031            Impact factor:   2.503


  6 in total

Review 1.  Inhaled corticosteroid therapy in newly detected mild asthma.

Authors:  P M O'Byrne
Journal:  Drugs       Date:  1999       Impact factor: 9.546

Review 2.  Once-daily inhaled corticosteroids in children with asthma: dry powder inhalers.

Authors:  C Möller
Journal:  Drugs       Date:  1999       Impact factor: 9.546

Review 3.  Budesonide inhalation suspension: a review of its use in infants, children and adults with inflammatory respiratory disorders.

Authors:  K M Hvizdos; B Jarvis
Journal:  Drugs       Date:  2000-11       Impact factor: 9.546

4.  Increasing adherence to inhaled steroid therapy among schoolchildren: randomized, controlled trial of school-based supervised asthma therapy.

Authors:  Lynn B Gerald; Leslie A McClure; Joan M Mangan; Kathy F Harrington; Linda Gibson; Sue Erwin; Jody Atchison; Roni Grad
Journal:  Pediatrics       Date:  2009-02       Impact factor: 7.124

Review 5.  Once-daily inhaled corticosteroids in mild to moderate asthma: improving acceptance of treatment.

Authors:  L M Campbell
Journal:  Drugs       Date:  1999       Impact factor: 9.546

Review 6.  Budesonide at different doses for chronic asthma.

Authors:  N Adams; J Bestall; P W Jones
Journal:  Cochrane Database Syst Rev       Date:  2001
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.